Presentation VIVA 2017 Is Aspirin Really a Class I Medication in Peripheral Artery Disease? Presenter: Ehrin J. Armstrong September 19, 2017
Presentation Association of DAPT With Reduced Major Adverse Cardiovascular Events in Symptomatic PAD Presenter: E.J. Armstrong April 22, 2015
Presentation TRA2P TIMI-50 Subanalysis: Vorapaxar for Secondary Prevention in PAD Patients Presenter: 204599|MP Bonaca June 22, 2012